GlaxoSmithKline PharmaceuticalsGLAXO 
$33.44-1.06%24h
-1.06%24h
Global rank2525
Market cap$5.67B
Change 7d-2.20%
YTD Performance46.85%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of GlaxoSmithKline Pharmaceuticals (GLAXO)
As of November 2024, GlaxoSmithKline Pharmaceuticals has a market cap of $5.67B. This makes GlaxoSmithKline Pharmaceuticals the world's 2525th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of GlaxoSmithKline Pharmaceuticals from 2002 to 2024
-
Value:-
Market cap history of GlaxoSmithKline Pharmaceuticals from 2002 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $4.45B | 15.89% |
| 2023 | $3.84B | 43.94% |
| 2022 | $2.67B | -24.93% |
| 2021 | $3.56B | 8.17% |
| 2020 | $3.29B | 0.85% |
| 2019 | $3.26B | 6.27% |
| 2018 | $3.07B | 21.75% |
| 2017 | $2.52B | -8.81% |
| 2016 | $2.76B | -17.63% |
| 2015 | $3.35B | 3.61% |
| 2014 | $3.24B | 6.68% |
| 2013 | $3.03B | 38.29% |
| 2012 | $2.19B | 11.46% |
| 2011 | $1.97B | -16.79% |
| 2010 | $2.37B | 45.01% |
| 2009 | $1.63B | 40.09% |
| 2008 | $1.16B | 12.02% |
| 2007 | $1.04B | -11.67% |
| 2006 | $1.18B | 3.67% |
| 2005 | $1.14B | 45.67% |
| 2004 | $779.36M | 34.30% |
| 2003 | $580.33M | 87.85% |
| 2002 | $308.94M | - |
GLAXO Market Cap Today is $5.67B -1.06% - 19 Nov 2024
View largest stocks by market cap 
